Abbott Laboratories (MEX:ABT) Cyclically Adjusted FCF per Share: MXN70.00 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MEX:ABT Abbott Laboratories MEX:ABT
81 GF Score
Price MXN1,620.85
GF Value MXN2,295.51
Valuation Modestly Undervalued
View Full Analysis

What is Abbott Laboratories Cyclically Adjusted FCF per Share?

Abbott Laboratories MEX:ABT -1.23% 81 Cyclically Adjusted FCF per Share is MXN70.00 as of Mar. 2026. GuruFocus rates MEX:ABT with a GF Score™ of 81/100 and a GF Value™ of MXN2,295.51 (Modestly Undervalued).

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Abbott Laboratories's adjusted free cash flow per share for the three months ended in Mar. 2026 was MXN9.455. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is MXN70.00 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Abbott Laboratories's average Cyclically Adjusted FCF Growth Rate was 10.70% per year. During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was 8.10% per year. During the past 5 years, the average Cyclically Adjusted FCF Growth Rate was 5.60% per year. During the past 10 years, the average Cyclically Adjusted FCF Growth Rate was 0.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of Abbott Laboratories was 13.70% per year. The lowest was -4.90% per year. And the median was 7.20% per year.

As of today (2026-07-14), Abbott Laboratories's current stock price is MXN1620.85. Abbott Laboratories's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2026 was MXN70.00. Abbott Laboratories's Cyclically Adjusted Price-to-FCF of today is 23.16.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Abbott Laboratories was 48.66. The lowest was 11.59. And the median was 32.57.


Abbott Laboratories  (MEX:ABT) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Abbott Laboratories's Cyclically Adjusted Price-to-FCF of today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/Cyclically Adjusted FCF per Share
=1620.85/70.00
=23.16

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Abbott Laboratories was 48.66. The lowest was 11.59. And the median was 32.57.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Abbott Laboratories Cyclically Adjusted FCF per Share Related Terms


Abbott Laboratories Cyclically Adjusted FCF per Share Historical Data

* Premium members only.

The historical data trend for Abbott Laboratories's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Abbott Laboratories Cyclically Adjusted FCF per Share Chart

Abbott Laboratories Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 60.98 56.81 51.01 70.82 68.12

Abbott Laboratories Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 70.72 68.63 67.47 68.12 70.00

MEX:ABT vs SYK, MDT, BSX: Cyclically Adjusted FCF per Share Comparison

For the Medical Devices subindustry, Abbott Laboratories's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Abbott Laboratories Cyclically Adjusted Price-to-FCF vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Abbott Laboratories's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Abbott Laboratories's Cyclically Adjusted Price-to-FCF falls into.


MEX:ABT
81GF Score
Abbott Laboratories MEX:ABT
Cyclically Adjusted FCF per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Abbott Laboratories Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Abbott Laboratories's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2026 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=9.455/330.2130*330.2130
=9.455

Current CPI (Mar. 2026) = 330.2130.

Abbott Laboratories Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201606 8.269 241.018 11.329
201609 11.852 241.428 16.211
201612 11.823 241.432 16.171
201703 3.277 243.801 4.438
201706 11.328 244.955 15.271
201709 18.022 246.819 24.111
201712 14.471 246.524 19.384
201803 8.573 249.554 11.344
201806 10.508 251.989 13.770
201809 19.310 252.439 25.259
201812 14.368 251.233 18.885
201903 4.116 254.202 5.347
201906 6.383 256.143 8.229
201909 17.118 256.759 22.015
201912 20.982 256.974 26.962
202003 4.675 258.115 5.981
202006 8.793 257.797 11.263
202009 19.399 260.280 24.611
202012 34.654 260.474 43.932
202103 25.558 264.877 31.862
202106 19.037 271.696 23.137
202109 25.746 274.310 30.993
202112 28.236 278.802 33.443
202203 19.568 287.504 22.475
202206 23.144 296.311 25.792
202209 26.380 296.808 29.349
202212 19.090 296.797 21.239
202303 7.851 301.836 8.589
202306 6.817 305.109 7.378
202309 13.122 307.789 14.078
202312 22.198 306.746 23.896
202403 5.947 312.332 6.287
202406 14.929 314.175 15.691
202409 24.213 315.301 25.358
202412 25.691 315.605 26.880
202503 10.924 319.799 11.280
202506 16.616 322.561 17.010
202509 24.024 324.800 24.424
202512 27.104 324.054 27.619
202603 9.455 330.213 9.455

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

What does a Cyclically Adjusted FCF per Share of MXN70.00 mean?
Abbott Laboratories (MEX:ABT) has a Cyclically Adjusted FCF per Share of MXN70.00 as of Mar. 2026. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Abbott Laboratories and its competitors.
Is Abbott Laboratories' Cyclically Adjusted FCF per Share too high?
Abbott Laboratories' current Cyclically Adjusted FCF per Share is MXN70.00. Overall, Abbott Laboratories has a GF Score™ of 81/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Abbott Laboratories' Cyclically Adjusted FCF per Share compare to SYK and MDT?
Abbott Laboratories' Cyclically Adjusted FCF per Share of MXN70.00 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted FCF per Share for a Medical Devices & Instruments company?
A good Cyclically Adjusted FCF per Share depends on the Medical Devices & Instruments industry context. However, Cyclically Adjusted FCF per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted FCF per Share mean?
A high Cyclically Adjusted FCF per Share can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Abbott Laboratories and its competitors. Abbott Laboratories's current Cyclically Adjusted FCF per Share is MXN70.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Abbott Laboratories stock overvalued right now?
Based on GuruFocus' analysis, Abbott Laboratories (MEX:ABT) is currently considered Modestly Undervalued. The stock's GF Value™ is MXN2,295.51, compared to a current price of MXN1,620.85 — trading 29.4% below its estimated fair value. The current Cyclically Adjusted FCF per Share is MXN70.00. Abbott Laboratories' overall GF Score™ is 81/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted FCF per Share calculated?
Cyclically Adjusted FCF per Share is calculated from a company's financial statements. For Abbott Laboratories (MEX:ABT), the current Cyclically Adjusted FCF per Share is MXN70.00 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Abbott Laboratories (MEX:ABT) Overvalued in 2026?

Based on GuruFocus' analysis, Abbott Laboratories stock appears to be undervalued. The current stock price of MXN1,620.85 is trading 29.4% below its estimated GF Value™ of MXN2,295.51. GuruFocus considers Abbott Laboratories to be Modestly Undervalued.

Key valuation signals for MEX:ABT:

  • Cyclically Adjusted FCF per Share: MXN70.00
  • GF Value™: MXN2,295.51 vs. price of MXN1,620.85 (29.4% below fair value)
  • GF Score™: 81/100

No single metric tells the full story. See the MEX:ABT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Abbott Laboratories Business Description

Address 100 Abbott Park Road, Abbott Park, IL, USA, 60064-6400
Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives roughly 60% of sales outside the United States.
81GF Score

Get the complete analysis for MEX:ABT

Cyclically Adjusted FCF per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN1,620.85
Price
MXN2,295.51
GF Value